Breaking News, Promotions & Moves

Crystalys Therapeutics Taps Justin Thacker as CFO

Thacker brings over 25 years of finance leadership experience, including over two decades in the life sciences sector.

Author Image

By: Charlie Sternberg

Associate Editor

Justin Thacker.

Crystalys Therapeutics Inc., a clinical-stage biopharmaceutical company addressing the medical needs of people living with gout, has appointed Justin Thacker as Chief Financial Officer (CFO). “We are incredibly excited to welcome Justin to our executive team,” remarked James M. Mackay, Ph.D., CEO and President of Crystalys. “Justin brings exceptional expertise and a proven track record of financial stewardship and strategic transactions. His experience strengthens our organi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics